JP2020191901A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020191901A5 JP2020191901A5 JP2020141042A JP2020141042A JP2020191901A5 JP 2020191901 A5 JP2020191901 A5 JP 2020191901A5 JP 2020141042 A JP2020141042 A JP 2020141042A JP 2020141042 A JP2020141042 A JP 2020141042A JP 2020191901 A5 JP2020191901 A5 JP 2020191901A5
- Authority
- JP
- Japan
- Prior art keywords
- primary
- lymphocytes
- lymphocyte
- nucleic acid
- contacting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023000651A JP2023040152A (ja) | 2014-07-11 | 2023-01-05 | Ｔリンパ球へのベクター導入効率の改善方法 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462023618P | 2014-07-11 | 2014-07-11 | |
| US62/023,618 | 2014-07-11 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522459A Division JP6754761B2 (ja) | 2014-07-11 | 2015-07-10 | Ｔリンパ球へのベクター導入効率の改善方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000651A Division JP2023040152A (ja) | 2014-07-11 | 2023-01-05 | Ｔリンパ球へのベクター導入効率の改善方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2020191901A JP2020191901A (ja) | 2020-12-03 |
| JP2020191901A5 true JP2020191901A5 (https=) | 2021-03-18 |
Family
ID=55064944
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522459A Active JP6754761B2 (ja) | 2014-07-11 | 2015-07-10 | Ｔリンパ球へのベクター導入効率の改善方法 |
| JP2020141042A Pending JP2020191901A (ja) | 2014-07-11 | 2020-08-24 | Ｔリンパ球へのベクター導入効率の改善方法 |
| JP2023000651A Pending JP2023040152A (ja) | 2014-07-11 | 2023-01-05 | Ｔリンパ球へのベクター導入効率の改善方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017522459A Active JP6754761B2 (ja) | 2014-07-11 | 2015-07-10 | Ｔリンパ球へのベクター導入効率の改善方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023000651A Pending JP2023040152A (ja) | 2014-07-11 | 2023-01-05 | Ｔリンパ球へのベクター導入効率の改善方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US10982189B2 (https=) |
| EP (2) | EP3167058B1 (https=) |
| JP (3) | JP6754761B2 (https=) |
| ES (2) | ES2813437T3 (https=) |
| WO (1) | WO2016007827A1 (https=) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3608022A1 (en) | 2013-03-15 | 2020-02-12 | The Trustees of Princeton University | Methods and devices for high throughput purification |
| US12590955B2 (en) | 2013-03-15 | 2026-03-31 | Zeon Corporation | Methods and systems for processing particles |
| US20150064153A1 (en) | 2013-03-15 | 2015-03-05 | The Trustees Of Princeton University | High efficiency microfluidic purification of stem cells to improve transplants |
| US11493428B2 (en) | 2013-03-15 | 2022-11-08 | Gpb Scientific, Inc. | On-chip microfluidic processing of particles |
| JP6754761B2 (ja) | 2014-07-11 | 2020-09-16 | セルジーン コーポレイション | Ｔリンパ球へのベクター導入効率の改善方法 |
| US10976232B2 (en) | 2015-08-24 | 2021-04-13 | Gpb Scientific, Inc. | Methods and devices for multi-step cell purification and concentration |
| CN111065399B (zh) | 2017-09-01 | 2023-11-28 | Gpb科学有限公司 | 使用微流体制备治疗活性细胞的方法 |
| DE102018100967B4 (de) | 2018-01-17 | 2019-08-14 | Immatics US, Inc. | Verfahren zur feststellung der wirksamkeit von viralen vektoren |
| DE102018010282A1 (de) | 2018-01-17 | 2019-07-18 | Immatics US, Inc. | Verfahren zur Feststellung der Wirksamkeit von viralen Vektoren |
| CN108715865B (zh) * | 2018-05-28 | 2021-09-21 | 福建师范大学 | 用于提高细胞转染效率的试剂组合物 |
| WO2021011907A1 (en) | 2019-07-18 | 2021-01-21 | Gpb Scientific, Inc. | Ordered processing of blood products to produce therapeutically active cells |
| JP2023508465A (ja) | 2019-12-28 | 2023-03-02 | ジーピービー・サイエンティフィック・インコーポレイテッド | 粒子および細胞を処理するためのマイクロ流体カートリッジ |
| AU2022253611B2 (en) * | 2021-04-06 | 2026-04-09 | Unicet Biotech Co. Llc | METHODS TO IMPROVE STABILITY OF VIRUS TRANSDUCTION OF γδ T CELLS AND APPLICATIONS THEREOF |
| WO2023286088A1 (en) * | 2021-07-16 | 2023-01-19 | Indian Institute Of Science Education And Research Bhopal | Methods and compositions for viral vector transduction |
| WO2025180499A1 (zh) * | 2024-02-28 | 2025-09-04 | 南京因领生物科技有限公司 | 一种提高细胞中病毒包装产量或质量的方法 |
| CN119530302B (zh) * | 2025-01-22 | 2025-06-27 | 青岛华赛伯曼医学细胞生物有限公司 | 提高til细胞的慢病毒转导效率及转导稳定性的方法及试剂盒 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6534055B1 (en) | 1988-11-23 | 2003-03-18 | Genetics Institute, Inc. | Methods for selectively stimulating proliferation of T cells |
| US6352694B1 (en) | 1994-06-03 | 2002-03-05 | Genetics Institute, Inc. | Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells |
| US5665577A (en) | 1989-02-06 | 1997-09-09 | Dana-Farber Cancer Institute | Vectors containing HIV packaging sequences, packaging defective HIV vectors, and uses thereof |
| IL104570A0 (en) | 1992-03-18 | 1993-05-13 | Yeda Res & Dev | Chimeric genes and cells transformed therewith |
| US8211422B2 (en) | 1992-03-18 | 2012-07-03 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Chimeric receptor genes and cells transformed therewith |
| CA2220226C (en) * | 1995-05-04 | 2008-10-21 | Carl H. June | Improved methods for transfecting t cells |
| US6692964B1 (en) | 1995-05-04 | 2004-02-17 | The United States Of America As Represented By The Secretary Of The Navy | Methods for transfecting T cells |
| US5948893A (en) | 1996-01-17 | 1999-09-07 | The United States Of America As Represented By The Secretary Of The Navy | Murine hybridoma and antibody binding to CD28 receptor secreted by the hybridoma and method of using the antibody |
| US5994136A (en) | 1997-12-12 | 1999-11-30 | Cell Genesys, Inc. | Method and means for producing high titer, safe, recombinant lentivirus vectors |
| ATE528406T1 (de) | 1999-04-29 | 2011-10-15 | Gbp Ip Llc | Verfahren und mittel zur herstellung von sicheren,rekombinanten lentivirusvektoren mit hohem titer |
| EP2316919B1 (en) | 2001-02-14 | 2015-10-07 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
| WO2004094605A2 (en) * | 2003-04-17 | 2004-11-04 | Mount Sinai School Of Medicine Of New York University | Methods and compositions for inhibiting stat signaling pathways |
| WO2004098531A2 (en) * | 2003-05-05 | 2004-11-18 | Virxsys Corporation | Increased transduction using abc transporter substrates and/or inhibitors |
| MX2007010008A (es) * | 2005-02-16 | 2008-01-18 | Lentigen Corp | Vectores lentivirales y su uso. |
| GB0526255D0 (en) * | 2005-12-22 | 2006-02-01 | Novartis Ag | Organic compounds |
| PT2471904T (pt) | 2005-12-29 | 2019-02-25 | Celularity Inc | População de células estaminais placentárias |
| WO2008153742A2 (en) * | 2007-05-23 | 2008-12-18 | Sangamo Biosciences, Inc. | Methods and compositions for increased transgene expression |
| NZ599825A (en) | 2007-09-28 | 2014-10-31 | Anthrogenesis Corp | Tumor suppression using human placental perfusate and human placenta-derived intermediate natural killer cells |
| AU2009316541B2 (en) | 2008-11-19 | 2015-08-06 | Celularity Inc. | Amnion derived adherent cells |
| ES2666746T3 (es) | 2010-07-13 | 2018-05-07 | Anthrogenesis Corporation | Métodos para generar linfocitos citolíticos naturales |
| WO2012072096A1 (en) | 2010-12-03 | 2012-06-07 | Biontech Ag | Method for cellular rna expression |
| EP2820138B1 (en) * | 2012-02-29 | 2020-10-28 | Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) | Retroviral transduction using poloxamers |
| RU2766608C2 (ru) * | 2012-04-11 | 2022-03-15 | Дзе Юнайтед Стейтс Оф Америка, Эз Репрезентед Бай Дзе Секретари, Департмент Оф Хелс Энд Хьюман Сёрвисез | Химерные антигенные рецепторы, нацеленные на антиген созревания b-клеток |
| WO2014046617A1 (en) * | 2012-09-19 | 2014-03-27 | Agency For Science, Technology And Research | Compositions and methods for treating cancer |
| JP6754761B2 (ja) * | 2014-07-11 | 2020-09-16 | セルジーン コーポレイション | Ｔリンパ球へのベクター導入効率の改善方法 |
-
2015
- 2015-07-10 JP JP2017522459A patent/JP6754761B2/ja active Active
- 2015-07-10 ES ES15818898T patent/ES2813437T3/es active Active
- 2015-07-10 US US15/325,376 patent/US10982189B2/en active Active
- 2015-07-10 EP EP15818898.7A patent/EP3167058B1/en active Active
- 2015-07-10 EP EP20176483.4A patent/EP3750993B1/en active Active
- 2015-07-10 WO PCT/US2015/039892 patent/WO2016007827A1/en not_active Ceased
- 2015-07-10 ES ES20176483T patent/ES2973524T3/es active Active
-
2020
- 2020-08-24 JP JP2020141042A patent/JP2020191901A/ja active Pending
-
2021
- 2021-03-12 US US17/200,745 patent/US11629335B2/en active Active
-
2023
- 2023-01-05 JP JP2023000651A patent/JP2023040152A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020191901A5 (https=) | ||
| JP2023040152A5 (https=) | ||
| Henderson et al. | Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III | |
| Cohen et al. | Early preservation of CXCR5+ PD-1+ helper T cells and B cell activation predict the breadth of neutralizing antibody responses in chronic HIV-1 infection | |
| JP2017521101A5 (https=) | ||
| Yuan et al. | Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker | |
| US7247474B2 (en) | Monoclonal antibody which specifically binds to but does not activate the CD8+ cells | |
| JP3356280B2 (ja) | 哺乳動物免疫不全ウイルスの検出 | |
| RU2010116849A (ru) | Профилактическая вакцина против вич, основанная на вич-специфических антителах | |
| Jia et al. | Development of broadly neutralizing antibodies and their mapping by monomeric gp120 in human immunodeficiency virus type 1-infected humans and simian-human immunodeficiency virus SHIVSF162P3N-infected macaques | |
| CN110272488A (zh) | 猫杯状病毒单克隆抗体及其应用 | |
| Silva de Castro et al. | Expression of CD40L by the ALVAC-simian immunodeficiency virus vector abrogates T cell responses in macaques | |
| Hu et al. | Immune complexes that bind to ELISA plates not coated with antigen in mice infected with lactate dehydrogenase-elevating virus: relationship to IgG2a-and IgG2b-specific polyclonal activation of B cells | |
| Eslahpazir et al. | Infection of macrophages and dendritic cells with primary R5-tropic human immunodeficiency virus type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions | |
| CN120943950B (zh) | 特异性结合呼吸道合胞病毒的抗体或其抗原结合片段及应用 | |
| CN118063602B (zh) | 一种从shiv攻毒的恒河猴体内分离的v3中和抗体 | |
| Peters et al. | Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: Studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera | |
| Adler et al. | Cell membrane coating with glutaraldehyde: application to a versatile solid-phase assay for thyroid membrane proteins and molecules interacting with thyroid membranes | |
| CN114805589B (zh) | 可同时识别牛、山羊、绵羊抗体的单克隆抗体 | |
| Duggan et al. | SOSIP trimer-specific antibodies isolated from a simian-human immunodeficiency virus-infected monkey with versus without a pre-blocking step with gp41 | |
| CN113325173B (zh) | 新型冠状病毒检测试剂盒 | |
| Yue et al. | Modification and Immune Function of Porcine PD-1 and PD-L1 Interaction Epitope Peptides | |
| Aida et al. | Antigenic regions defined by monoclonal antibodies on tumor-associated antigens of bovine leukemia virus-induced lymphosarcoma cells | |
| Gorbunova et al. | THE USE OF PEPTIDE SEQUENCES OF IMMUNOGENIC EPITOPES OF THE BOVINE LEUKEMIA VIRUS TO IDENTIFY SPECIFIC ANTIBODIES | |
| JP4310499B2 (ja) | 活性化リンパ球を同種補体を介して溶解させるヒトＩｇＭ抗体 |